000			02087 a2200565 4500
005			20250515081146.0
264		0	_c20071227
008			200712s 0 0 eng d
022			_a0959-8049
024	7		_a10.1016/j.ejca.2007.06.024 _2doi
040			_aNLM _beng _cNLM
100	1		_ade Korte, M A
245	0	0	_a111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity. _h[electronic resource]
260			_bEuropean journal of cancer (Oxford, England : 1990) _cSep 2007
300			_a2046-51 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnthracyclines _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aChronic Disease
650	0	4	_aFemale
650	0	4	_aHeart Diseases _xchemically induced
650	0	4	_aHeart Failure _xmetabolism
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPentetic Acid
650	0	4	_aReceptor, ErbB-2 _xmetabolism
650	0	4	_aStress, Physiological _xchemically induced
650	0	4	_aTomography, Emission-Computed, Single-Photon _xmethods
650	0	4	_aTrastuzumab
650	0	4	_aUp-Regulation
700	1		_ade Vries, E G E
700	1		_aLub-de Hooge, M N
700	1		_aJager, P L
700	1		_aGietema, J A
700	1		_avan der Graaf, W T A
700	1		_aSluiter, W J
700	1		_avan Veldhuisen, D J
700	1		_aSuter, T M
700	1		_aSleijfer, D T
700	1		_aPerik, P J
773	0		_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 43 _gno. 14 _gp. 2046-51
856	4	0	_uhttps://doi.org/10.1016/j.ejca.2007.06.024 _zAvailable from publisher's website
999			_c17250076 _d17250076